Increased susceptibility of mice to Salmonella infection following in vivo treatment with the substance P antagonist, spantide II

Journal of Immunology

Volumn 157, Issue 1, 1996, Pages 255-264

  Kincy Cain, Tammy ^a   Bost, Kenneth L ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 12; SPANTIDE; SUBSTANCE P ANTAGONIST;

ANIMAL CELL; ANTIBODY PRODUCTION; ANTIGEN SPECIFICITY; ARTICLE; CELL POPULATION; GENE EXPRESSION; GENETIC SUSCEPTIBILITY; IMMUNE RESPONSE; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; PEYER PATCH; PRIORITY JOURNAL; SALMONELLOSIS; SURVIVAL RATE;

ADMINISTRATION, ORAL; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CELLS, CULTURED; DISEASE SUSCEPTIBILITY; FEMALE; INTERFERON TYPE II; INTERLEUKIN-12; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MACROPHAGE ACTIVATION; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; RECEPTORS, NEUROKININ-1; RNA, MESSENGER; SALMONELLA INFECTIONS, ANIMAL; SUBSTANCE P;

EID: 0029896011     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Buchwald, D. S., and M. J. Blaser. 1984. A review of human salmonellosis. Rev. infect. Dis. 6:345.
2. Hsu, H. S. 1989. Pathogenesis and immunity in murine salmonellosis. Microbiol. Rev. 53:390.
3. Bost, K. L., and J. D. Clements. 1995. In vivo induction of interleukin-12 mRNA expression after oral immunization with Salmonella dublin or the B subunit of Escherichia coli heat-labile enterotoxin. Infect. Immun. 63:1076.
4. Kincy-Cain, T., J. D. Clements, and K. L. Bost. 1996. Endogenous and exogenous interleukin-12 augment the protective immune response in mice orally challenged with Salmonella dublin. Infect. Immun. 64:1437.
5. Mastronei, P., J A. Harrison, S. A. Chabalgoity, and C. E. Hormaeche. 1996. Effect of interleukin-12 neutralization on host resistance and gamma-interferon production in mouse typhoid. Infect. immun. 64:189.
6. Chong, C., K. L. Bost, and J. D. Clements. 1996. Differential production of IL-12 mRNA by murine macrophages in response to viable or killed Salmonella spp. Infect. Immun. 64:1154.
7. Ramarathinam, L., R. A. Shaban, D. W. Niesel, and G. R. Kumpel. 1991. Interferon-gamma production by gut-associated lymphoid tissue and spleen following oral Salmonella typhimurium challenge. Microb. Pathog. 11:347.
8. Ramarathinam, L., D. W. Neisel, and G. R. Klimpel. 1993. Salmonella typhimurium induces interferon-gamma production in murine splenocytes. J. Immunol. 150:3973.
9. Gazzinelli, R. T., S. Hieny, T. A. Wynn, S. Wolf, and A. Sher. 1993. IL-12 is required for the T-lymphocyte-independent induction of interferon-gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc. Natl. Acad. Sci. USA 90:6115.
10. Heinzel, F. P., D. S. Schoenhaut, R. M. Rerko, L. E. Rosser, and M. K. Gately. 1993. Recombinant IL-12 cures mice infected with Leishmania major. J. Exp. Med. 177:1505.
11. Sypek, J. P., C. L. Chung, S. E. H. Mayor, J. M. Subramanyam, S. J. Goldman, D. S. Sieburth, S. F. Wolf, and R. G. Schaub. 1993. Resolution of cutaneous leishmaniasis: Interleukin-12 initiates a protective T helper type 1 immune response. J. Exp. Med 177:1797.
12. Hunter, C. A., C. S. Subauste, V. H. Van Cleave, and J. S. Remington. 1994. Production of gamma interferon by natural killer cells from Toxoplasma gondiiinfected SCID mice. Infect. Immun. 62:2818.
13. Khan, I. A., T. Matsuura, and L. H. Kasper. 1994. IL-12 enhances murine survival against acute toxoplasmosis. Infect. Immun. 62:1639.
14. Orange, J. S., S. F. Wolf, and C. A. Biron. 1994. Effects of IL-12 on the response and susceptibility to experimental viral infections. J. Immunol. 152:1253.
15. Tripp, C. S., M. K. Gately, J. Hakimi, P. Ling, and E. R. Unanue. 1994. Neutralization of IL-12 decreases resistance to Listeria in SC1D and C. B-17 mice: reversal by γ-interferon. J. Immunol. 152:1883.
16. Vieira, L. Q., B. D. Hondowicz, L. C. C. Afonso, M. Wysocka, G. Trinchieri, and P. Scott. 1994. Infection with Leishmania major induces interleukin-12 production in vivo. Immunol. Lett. 40:157.
17. Cooper, A. M., A. D. Roberts, E. R. Rhoades, J. E. Callahan, D. M. Getzy, and I. M. Orme. 1995. The role of IL-12 in acquired immunity to Mycobacterium tuberculosis infection. Immunology 84:423.
18. Flynn, J. L., M. M. Goldstein, K. J. Triebold, J. Sypek, S. Wolf, and B. R. Bloom. 1995. IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J. Immunol. 155:2515.
19. Murray, H. W., and I. Hariprashad. 1995. Interleukin-12 is effective treatment for an established systemic intracellular infection: experimental visceral leishmaniasis. J. Exp. Med. 181:387.
20. Zhan, Y., and C. Cheers. 1995. Endogenous interleukin-12 is involved in resis-tance to Brucella abortus infection. Infect. Immun. 63:1387.
21. Bost, K. L. 1995. Inducible preprotachykinin mRNA expression in mucosal lymphoid organs following oral immunization with Salmonella. J. Neuroimmunol. 62:59.
22. Folkers, K., D. M. Feng, N. Asano, R. Hakanson, Z. Weisenfeld-Hallin, and S. Leander. 1990. spantide II, an effective tachykinin antagonist having high potency and negligible neurotoxicity. Proc. Natl. Acad. Sci. USA 87:4833.
23. Hakanson, R., S. Leander, N. Asano, D.-M. Feng, and K. Folkers. 1990. spantide II, a novel tachykinin antagonist having high potency and low histamine-releasing effect. Regul. Pept. 31:75.
24. Bost, K. L., and M. J. Mason. 1995. Thapsigargin and cyclopiazonic acid initiate rapid and dramatic increases of IL-6 mRNA expression and IL-6 secretion in murine peritoneal macrophages. J. Immunol. 155:285.
25. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acidic guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156.
26. Bost, K. L., S. C. Bieligk, and B. M. Jaffe. 1995. Lymphokine mRNA expression by transplantable murine B lymphocytic malignancies: tumor-derived IL-10 as a possible mechanism for affecting the anti-tumor response. J. Immunol. 154:718.
27. Yokata, Y., Y. Sasai, K. Tanaka, T. Fujiwara, K. Tsuchida, R. Shigemoto, A. Kakizuka, H. Ohkubo, and S. Nakanishi. 1989. Molecular characterization of a functional cDNA for rat substance P receptor. J. Biol. Chem. 264:17649.
28. Hershey, A. D., and J. E. Krause. 1990. Molecular characterization of a functional cDNA encoding the rat substance P receptor. Science 247:958.
29. Sundelin, J. B., D. M. Provvedini, C. R. Wahlestedt, H. Laurell. J. S. Pohl, and P. A. Peterson. 1992. Molecular cloning of the murine substance K and substance P receptor genes. Eur. J. Biochem. 203:625.
30. Noma, Y., P. Sideras, T. Naito, S. Bergstedt-Lindquist, C. Azuma, E Severrinson, T. Tanabe, T. Kinashi, F. Matsuda, Y. Yaoita, and T. Honjo. 1986. Cloning of cDNA encoding the murine IgG1 induction factor by a novel strategy using SP6 promoter. Nature 319:640.
31. Van Snick, J., S. Cayphas, J. P. Szikora, J. C. Renauld, E. Van Roost, T. Boon, and R. J. Simpson. 1988. cDNA cloning of murine interleukin-HP1: homology with human interleukin 6. Eur. J. Immunol. 18:193.
32. Moore, K. W., P. Vieira, D. F. Fiorentino, M. L. Trounstine, T. A. Khan, and T. R. Mosmann. 1990. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein Barr virus gene BCRFI. Science 248:1230.
33. Schoenhaut, D. S., A. O. Chua, A. G. Wolitzky, P. M. Quinn, C. M. Dwyer, W. McComas, P. C. Familletti, M. K. Gately, and U. Gubler. 1992. Cloning and expression of murine IL-12. J. Immunol. 148:3433.
34. Gray, P. W., and D. V. Goeddel. 1983. Cloning and expression of murine immune interferon cDNA. Proc. Natl. Acad. Sci. USA 80:5842.
35. Brosius. J., M. L. Palmer, P. J. Kennedy, and H. F. Noller. 1978. Complete nucleotide scquence of a 16S ribosomal RNA gene from Escherichia coli. Proc. Natl. Acad. Sci. USA 75:4801.
36. Sabath, D. E., H. E. Broome, and M. B. Prystowski. 1990. Glyceraldehyde-3-phosphate dehydrogenase is a major 1L-2 induced transcript in a cloned T helper lymphocyte. Gene 91:185.
37. Bost. K. L. 1995. Quantification of macrophage-derived substance P receptor mRNA using competitive polymerase chain reaction. In The Brain Immune Axis and Substance Abuse. B. Sharp, H. Friedman, J. Madden, and T. Eisenstein, eds. Plenum Press, New York, p. 219.
38. Pascual, D. W., and K. L. Bost. 1990. 5′-3′ and 3′-5′ translation of the same RNA results in hydropathically similar peptides that are antigenically similar. Immunol. Invest. 19:421.
39. Pascual, D. W., J, R. McGhee, H. Kiyono, and K. L. Bost. 1991. Neuroimmune modulation of lymphocyte function. I. Substance P enhances Immunoglobulin synthesis in LPS activated murine splenic B cell cultures. Int. Immunol. 3:1223.
40. Pascual, D. W., J. Xu-Amano, H. Kiyono, J. R. McGhee, and Bost, K. L. 1991. Substance P acts directly upon cloned B lymphoma cells to enhance IgA and IgM production. J. Immunol. 146:2130.
41. Regoli, D., A. Boudon, and J.-L. Fauchere. 1994. Receptors and anatgonists for substance P and related peptides. Pharmacol. Rev. 46:551.
42. Pernow, B. 1983. Substance P. Pharmacol. Rev. 35:85.
43. Pothoulakis, C., I. Castagliuolo, J. T. LaMont, A. Jaffer, J. C. O'Keane, R. M. Snider, and S. E. Leeman. 1994. CP-36,345, a substance P antagonist, inhibits rat intestinal responses to Clostridium difficile toxin A but not cholera toxin. Proc. Natl. Acad. Sci. USA 91:947.
44. Helme, R. D., A. Eglezos, G. W. Dandie, P. V. Andrews, and R. L. Boyd. 1987. The effect of substance P on the regional lymph node antibody response to antigenic stimulation in capsaicin pretreated rats. J. Immunol. 139:3470.
45. Eglezos, A., P. V. Andrews, R. L. Boyd, and R. D. Helme. 1990. Effects of capsaicin treatment on immunoglobulin secretion in the rat: further evidence for involvement of tachykinin-containing afferent nerves. J Neuroimmunol. 26:131.
46. Scicchitano, R., J. Biennenstock, and A. M. Stanisz. 1988. In vivo modulation by the neuropeptide substance P. Immunology 63:733.
47. Bost, K. L., and D. W. Pascual. 1992. Substance P: a late acting B lymphocyte differentiation cofactor. Am. J. Physiol. 262:C537.
48. Hurtung, H. P., K. Wolters, and K. V. Toyker. 1986. Substance P: binding properties and studies on cellular responses in guinea pig macrophages. J. Immunol. 136:3856.
49. Lotz, M., J. H. Vaughan, and D. A. Carson. 1988. Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science 241:1218.
50. Kimball, E. S., F. J. Persico, and J. L. Vaught. 1988. Substance P, neurokinin A, and neurokinin B induce generation of IL-1-like activity in P388D1 cells. J. Immunol. 141:3564.
51. Bost, K. L., S. L. Breeding, and D. W. Pascual. 1992. Modulation of the mRNAs encoding substance P and its receptor in macrophages by LPS. Region. Immunol. 4:105.
52. Pascual, D. W., and K. L. Bost. 1990. Substance P production by P388DI macrophages: a possible autocrine mechanism of interaction. Immunology 71:52.
53. Li, Y. M., M. Marnerakis, E. R. Stimson, and J. E. Maggio. 1995. Mapping peptide-binding domains of the substance P (NK-1) receptor from P388DI cells with photolabilc agonists. J Biol. Chem. 270:1213.
54. Koch, T. R., J, A. Carney, and V. L. W. Go. 1987. Distribution and quantification of gut neuropeptides in normal intestine and inflammatory bowel diseases. Dig. Dis. Sci. 32:369.
55. Popper, P., C. R. Mantyh, S. R. Vigna, J. E. Maggio, and P. W. Mantyh. 1988. The localization of sensory nerve fibers and receptor binding sites for sensory neuropeptides in canine mesenteric lymph nodes. Peptides 9:257.
56. Ichikawa, S., S. P. Sreedharan, E. J. Goetzl, and R. L. Owen. 1994. Immunohistochemical localization of peptidergic nerve fibers and neuropeptide receptors in Peyer's patches of the cat ileum. Regul. Pept. 54:385.
57. Pascual, D. W., A. M. Stanisz, and K. L. Bost. 1994. Functional aspects of the peptidergic circuit to inucosal immunity. In Handbook of Mucosal Immunolgy, P. L. Ogra, M. E. Lamm, J. R. McGhee, J. Mcstecky, W. Strober, and J. Bienenstock, eds. Academic Press, New York, p. 203.